Zhejiang Jingxin Pharmaceutical Co., Ltd.
Informe acción SZSE:002020
Capitalización de mercado: CN¥11.1b
Zhejiang Jingxin Pharmaceutical Dividendos y recompras
Dividendo controles de criterios 6/6 Zhejiang Jingxin Pharmaceutical es una empresa que paga dividendos con una rentabilidad actual de 2.33% que está bien cubierta por los beneficios.
Información clave
2.3%
Rentabilidad por dividendo
-0.004%
Rendimiento de la recompra
Rendimiento total para el accionista 2.3% Rendimiento futuro de los dividendos 3.0% Crecimiento de los dividendos 11.9% Próxima fecha de pago de dividendos n/a Fecha ex dividendo n/a Dividendo por acción CN¥0.300 Ratio de pago 36%
Últimas actualizaciones de dividendos y recompras
Zhejiang Jingxin Pharmaceutical (SZSE:002020) Has Announced A Dividend Of CN¥0.30 May 21
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces 2022 Final Profit Distribution Plan, Payable on 24 May 2023 May 19
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces 2021 Final Profit Distribution Plan, Payable on 25 May 2022 May 19
Zhejiang Jingxin Pharmaceutical Co., Ltd. Approves 2021 Profit Distribution Plan At the Annual General Meeting Held on April 22, 2022 Apr 27
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces the Final Profit Distribution Proposal for 2021 Mar 31
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2020, Payable on May 28, 2021 May 22
Mostrar todas las actualizaciones
Third quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.18 in 3Q 2023) Oct 25
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt Oct 04
Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024 Sep 30
Investor sentiment improves as stock rises 21% Sep 30
Zhejiang Jingxin Pharmaceutical Co., Ltd.'s (SZSE:002020) Low P/E No Reason For Excitement Sep 12
New minor risk - Earnings quality Aug 24
Now 21% overvalued Aug 16
Second quarter 2024 earnings released: EPS: CN¥0.27 (vs CN¥0.19 in 2Q 2023) Aug 15
Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report First Half, 2024 Results on Aug 15, 2024 Jun 29
Zhejiang Jingxin Pharmaceutical (SZSE:002020) Has Announced A Dividend Of CN¥0.30 May 21
Dividend of CN¥0.30 announced May 20
Zhejiang Jingxin Pharmaceutical's (SZSE:002020) Problems Go Beyond Weak Profit Apr 08
Full year 2023 earnings: EPS misses analyst expectations Mar 31 Zhejiang Jingxin Pharmaceutical Co., Ltd., Annual General Meeting, Apr 22, 2024
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt Mar 29
Investor sentiment deteriorates as stock falls 16% Feb 05
Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report Fiscal Year 2023 Results on Mar 30, 2024 Dec 29
Third quarter 2023 earnings released: EPS: CN¥0.18 (vs CN¥0.20 in 3Q 2022) Oct 27
Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.19 in 2Q 2022) Aug 15
New minor risk - Shareholder dilution Jul 07
Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report First Half, 2023 Results on Aug 15, 2023 Jul 01
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces 2022 Final Profit Distribution Plan, Payable on 24 May 2023 May 19
Full year 2022 earnings released: EPS: CN¥0.73 (vs CN¥0.75 in FY 2021) Mar 02
Third quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.20 in 3Q 2021) Oct 28
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces Directorate Appointments Oct 15
Investor sentiment improved over the past week Oct 14
Second quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.17 in 2Q 2021) Aug 26
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces 2021 Final Profit Distribution Plan, Payable on 25 May 2022 May 19
Zhejiang Jingxin Pharmaceutical Co., Ltd. Approves 2021 Profit Distribution Plan At the Annual General Meeting Held on April 22, 2022 Apr 27
High number of new directors Apr 27
Zhejiang Jingxin Pharmaceutical Co., Ltd., Annual General Meeting, Apr 22, 2022 Apr 02
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces the Final Profit Distribution Proposal for 2021 Mar 31
Full year 2021 earnings released: EPS: CN¥0.74 (vs CN¥0.82 in FY 2020) Mar 31
Investor sentiment improved over the past week Mar 24
Full year 2021 earnings: EPS misses analyst expectations Feb 27
Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.17 in 3Q 2020) Oct 28
Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.15 in 2Q 2020) Aug 27
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2020, Payable on May 28, 2021 May 22
First quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.13 in 1Q 2020) Apr 27
Full year 2020 earnings released: EPS CN¥0.98 (vs CN¥0.73 in FY 2019) Mar 30
Full year 2020 earnings released: EPS CN¥0.98 (vs CN¥0.73 in FY 2019) Mar 04
Earnings beat expectations, revenue disappoints Mar 04
New 90-day low: CN¥10.31 Dec 28
New 90-day low: CN¥10.72 Dec 12
New 90-day low: CN¥11.21 Nov 26
Third quarter earnings released Oct 28
Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report Q3, 2020 Results on Oct 28, 2020 Oct 20
Earnings released Aug 25
Zhejiang Jingxin Pharmaceutical Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020 Aug 02
New 90-day high - CN¥15.10 Jul 30
Zhejiang Jingxin Pharmaceutical Co., Ltd. announced that it expects to receive CNY 499.999996 million in funding from Jingxin Holding Group Co., Ltd. Jul 21
Estabilidad y crecimiento de los pagos
Obteniendo datos sobre dividendos
Dividendo estable: Los dividendos por acción de 002020 se han mantenido estables en los últimos 10 años.
Dividendo creciente: El pago de dividendos de 002020 ha aumentado en los últimos 10 años.
Rentabilidad por dividendo vs. Mercado Rentabilidad por dividendo de Zhejiang Jingxin Pharmaceutical vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de 002020 con la del mercado? Segmento Rentabilidad por dividendo Empresa (002020) 2.3% Suelo de mercado 25% (CN) 0.5% Techo de mercado 25% (CN) 2.1% Media de la industria (Pharmaceuticals) 1.6% Analista de previsiones (002020) (hasta 3 años) 3.0%
Dividendo destacado: El dividendo de 002020(2.33%) es más alto que el 25% inferior de los pagadores de dividendos del mercado CN (0.51%).
Alto dividendo: 002020(2.33%) se encuentra en el 25% superior de los pagadores de dividendos del mercado CN (2.06%)
Pago de beneficios a los accionistas
Cobertura de los beneficios: Con su razonablemente bajo ratio de pago (35.7%), los pagos de dividendos de 002020 están bien cubiertos por los beneficios.
Pago en efectivo a los accionistas
Cobertura de flujo de caja: Con su razonablemente bajo ratio de pago en efectivo (39.9%), los pagos de dividendos de 002020 están bien cubiertos por los flujos de caja.
Descubre empresas que pagan buenos dividendos Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
